433 related articles for article (PubMed ID: 7591260)
41. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
Park S; Tomlinson G; Nisen P; Haber DA
Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654
[TBL] [Abstract][Full Text] [Related]
42. A critical mutation in both WT1 alleles is not sufficient to cause Wilms' tumor.
Kikuchi H; Akasaka Y; Kurosawa Y; Yoneyama H; Kato S; Hata J
FEBS Lett; 1995 Feb; 360(1):26-8. PubMed ID: 7875294
[TBL] [Abstract][Full Text] [Related]
43. WT1 mutations may be a cause of severe renal failure due to nephroblastomatosis in Wilms' tumor patients.
Santín S; Fraga G; Ruíz P; Pardo N; Torrent M; Martí T; Ballarín J; Ars E; Torra R
Clin Nephrol; 2011 Sep; 76(3):244-8. PubMed ID: 21888862
[TBL] [Abstract][Full Text] [Related]
44. A third Wilms' tumor locus on chromosome 16q.
Maw MA; Grundy PE; Millow LJ; Eccles MR; Dunn RS; Smith PJ; Feinberg AP; Law DJ; Paterson MC; Telzerow PE
Cancer Res; 1992 Jun; 52(11):3094-8. PubMed ID: 1317258
[TBL] [Abstract][Full Text] [Related]
45. Wilms' tumor-specific methylation pattern in 11p13 detected by PFGE.
Royer-Pokora B; Schneider S
Genes Chromosomes Cancer; 1992 Sep; 5(2):132-40. PubMed ID: 1381949
[TBL] [Abstract][Full Text] [Related]
46. Vertical transmission of a mutation in exon 1 of the WT1 gene: lessons for genetic counseling.
Regev M; Kirk R; Mashevich M; Bistritzer Z; Reish O
Am J Med Genet A; 2008 Sep; 146A(18):2332-6. PubMed ID: 18688870
[TBL] [Abstract][Full Text] [Related]
47. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
[TBL] [Abstract][Full Text] [Related]
48. Low frequency of mutations in the WT1 coding region in Wilms' tumor.
Brown KW; Wilmore HP; Watson JE; Mott MG; Berry PJ; Maitland NJ
Genes Chromosomes Cancer; 1993 Oct; 8(2):74-9. PubMed ID: 7504520
[TBL] [Abstract][Full Text] [Related]
49. Responsiveness of chemotherapy based on the histological type and Wilms' tumor suppressor gene mutation in bilateral Wilms' tumor.
Shibata R; Takata A; Hashiguchi A; Umezawa A; Yamada T; Hata J
Pathol Int; 2003 Apr; 53(4):214-20. PubMed ID: 12675764
[TBL] [Abstract][Full Text] [Related]
50. Genetics of Wilms' tumor.
Coppes MJ; Egeler RM
Semin Urol Oncol; 1999 Feb; 17(1):2-10. PubMed ID: 10073400
[TBL] [Abstract][Full Text] [Related]
51. Polymerase chain reaction-based risk assessment for Wilms tumor in sporadic aniridia.
Gupta SK; De Becker I; Guernsey DL; Neumann PE
Am J Ophthalmol; 1998 May; 125(5):687-92. PubMed ID: 9625553
[TBL] [Abstract][Full Text] [Related]
52. Germline WT1 mutations in Wilms' tumor patients: preliminary results.
Li FP; Breslow NE; Morgan JM; Ghahremani M; Miller GA; Grundy PE; Green DM; Diller LR; Pelletier J
Med Pediatr Oncol; 1996 Nov; 27(5):404-7. PubMed ID: 8827066
[TBL] [Abstract][Full Text] [Related]
53. Allelic loss on chromosome 11p is a less frequent event in bilateral than in unilateral Wilms' tumours.
Little MH; Clarke J; Byrne J; Dunn R; Smith PJ
Eur J Cancer; 1992; 28A(11):1876-80. PubMed ID: 1356388
[TBL] [Abstract][Full Text] [Related]
54. Novel WT1 mutation, 11p LOH, and t(7;12) (p22;q22) chromosomal translocation identified in a Wilms' tumor case.
Löbbert RW; Klemm G; Grüttner HP; Harms D; Winterpacht A; Zabel BU
Genes Chromosomes Cancer; 1998 Apr; 21(4):347-50. PubMed ID: 9559347
[TBL] [Abstract][Full Text] [Related]
55. Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination.
Coppes MJ; Bonetta L; Huang A; Hoban P; Chilton-MacNeill S; Campbell CE; Weksberg R; Yeger H; Reeve AE; Williams BR
Genes Chromosomes Cancer; 1992 Nov; 5(4):326-34. PubMed ID: 1283321
[TBL] [Abstract][Full Text] [Related]
56. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
[TBL] [Abstract][Full Text] [Related]
57. Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor.
Malkin D; Sexsmith E; Yeger H; Williams BR; Coppes MJ
Cancer Res; 1994 Apr; 54(8):2077-9. PubMed ID: 8174107
[TBL] [Abstract][Full Text] [Related]
58. Cytogenetics and molecular genetics of Wilms' tumor of childhood.
Slater RM; Mannens MM
Cancer Genet Cytogenet; 1992 Jul; 61(2):111-21. PubMed ID: 1322233
[TBL] [Abstract][Full Text] [Related]
59. A constitutional BWS-related t(11;16) chromosome translocation occurring in the same region of chromosome 16 implicated in Wilms' tumors.
Newsham I; Kindler-Röhrborn A; Daub D; Cavenee W
Genes Chromosomes Cancer; 1995 Jan; 12(1):1-7. PubMed ID: 7534105
[TBL] [Abstract][Full Text] [Related]
60. Bilateral Wilms tumor and early presentation in pediatric patients is associated with the truncation of the Wilms tumor 1 protein.
Hu M; Fletcher J; McCahon E; Catchpoole D; Zhang GY; Wang YM; Algar EM; Alexander SI
J Pediatr; 2013 Jul; 163(1):224-9. PubMed ID: 23403252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
